The endovenous ablation devices market size has the potential to grow by $ 156.60 mn during 2021-2025, and the market’s growth momentum will accelerate during the forecast period.
This report provides a detailed analysis of the market by product (EVLT devices, RFA devices, and NTNT devices) and geography (North America, Europe, Asia, and ROW). Also, the report analyzes the market’s competitive landscape and offers information on several market vendors, including AngioDynamics Inc., AtriCure Inc., Eufoton srl, Johnson & Johnson, Medtronic Plc, Merit Medical Systems Inc., RF Medical Co. Ltd. , Sciton Inc., Teleflex Inc., and Venclose Inc. .
Market Overview
Browse TOC and LoE with selected illustrations and example pages of Endovenous Ablation Devices Market
Market Competitive Analysis
The endovenous ablation devices market is fragmented. AngioDynamics Inc., AtriCure Inc., Eufoton srl, Johnson & Johnson, Medtronic Plc, Merit Medical Systems Inc., RF Medical Co. Ltd. , Sciton Inc., Teleflex Inc., and Venclose Inc. are some of the major market participants. Factors such as increasing prevalence of cvi, growing demand for mi endovenous ablation procedures, and technological advances in endovascular ablation devices will offer immense growth opportunities. However, high cost coupled with unfavorable reimbursement policies, limitations and complications associated with endovenous ablation techniques, and shortage of skilled vascular surgeons may impede market growth. To make the most of the opportunities, vendors should focus on growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
To help clients improve their market position, this endovenous ablation devices market forecast report provides a detailed analysis of the market leaders and offers information on the competencies and capacities of these companies. The report also covers details on the market’s competitive landscape and offers information on the products offered by various companies. Moreover, this endovenous ablation devices market analysis report provides information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of future growth opportunities.
This report provides information on the production, sustainability, and prospects of several leading companies, including:
- AngioDynamics Inc.
- AtriCure Inc.
- Eufoton srl
- Johnson & Johnson
- Medtronic Plc
- Merit Medical Systems Inc.
- RF Medical Co. Ltd.Â
- Sciton Inc.
- Teleflex Inc.
- Venclose Inc.Â
|
Endovenous Ablation Devices Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
120 |
|
Base year |
2020 |
|
Forecast period |
2021-2025 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 6% |
|
Market growth 2021-2025 |
$ 156.60 million |
|
Market structure |
Fragmented |
|
YoY growth (%) |
5.04 |
|
Regional analysis |
North America, Europe, Asia, and ROW |
|
Performing market contribution |
North America at 45% |
|
Key consumer countries |
US, Germany, France, UK, China, and Japan |
|
Competitive landscape |
Leading companies, competitive strategies, consumer engagement scope |
|
Companies profiled |
AngioDynamics Inc., AtriCure Inc., Eufoton srl, Johnson & Johnson, Medtronic Plc, Merit Medical Systems Inc., RF Medical Co. Ltd. , Sciton Inc., Teleflex Inc., and Venclose Inc. |
|
Market Dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for forecast period, |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Endovenous Ablation Devices Market: Segmentation by Geography
For more insights on the market share of various regions Request for a FREE sample now!
The report offers an up-to-date analysis regarding the current Global market scenario, latest trends and drivers, and the overall market environment. North America will offer several growth opportunities to market vendors during the forecast period. The increasing popularity of performing endovenous procedures in an outpatient setting, emergence of endovenous steam ablation (evsa) as an alternative to evla and rfa, and strategic partnerships, m&a, and marketing initiatives by vendors will significantly influence endovenous ablation devices market's growth in this region.
45% of the market’s growth will originate from North America during the forecast period. US | Germany | France | UK | China | Japan are the key markets for endovenous ablation devices market in North America. This report provides an accurate prediction of the contribution of all segments to the growth of the endovenous ablation devices market size.
Endovenous Ablation Devices Market: Key Highlights of the Report for 2021-2025
- CAGR of the market during the forecast period 2021-2025
- Detailed information on factors that will drive endovenous ablation devices market growth during the next five years
- Precise estimation of the endovenous ablation devices market size and its contribution to the parent market
- Accurate predictions on upcoming trends and changes in consumer behavior
- The growth of the endovenous ablation devices market industry across North America, Europe, Asia, and ROW
- A thorough analysis of the market’s competitive landscape and detailed information on vendors
- Comprehensive details of factors that will challenge the growth of endovenous ablation devices market vendors
We can help! Our analysts can customize this report to meet your requirements. Get in touch